Literature DB >> 22825781

[Acute tubulointerstitial nephritis as hyperergic reaction of the kidneys].

A Schwarz1, J U Becker, H Haller.   

Abstract

Acute tubulointerstitial nephritis was formerly only observed during the early phase of infections. With the emergence of antibiotics this disease became a rarity. In contrast the importance of drug-associated acute tubulointerstitial nephritis grew in importance and is now the most common form and expression of a hyperergic reaction of the kidneys. Acute tubulointerstitial nephritis occurs as a third form in cases of systemic autoimmune diseases, e.g., in idiopathic tubulointerstitial nephritis or within the scope of Sjögrens syndrome with distal tubular acidosis. The common symptoms of the drug-induced form are fever, side pain, microhematuria or macrohematuria and a mostly sharp increase in creatinine levels but to a greatly differing extent. Histologically, there is interstitial edema and interstitial lymphocyte-rich infiltration with tubulitis. The symptoms can be subclinical or even non-existent. In most case remission occurs, sometimes only partial remission or transformation to chronic interstitial nephritis. Risk factors are for example delayed diagnosis, recurrent episodes and the accompanying use of analgesics. The more acute and intense the clinical symptoms are, the earlier the diagnosis and therefore the better the prognosis. A temporary steroid treatment can promote regression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22825781     DOI: 10.1007/s00108-012-3083-9

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  37 in total

1.  The outcome of acute interstitial nephritis: risk factors for the transition from acute to chronic interstitial nephritis.

Authors:  A Schwarz; P H Krause; U Kunzendorf; F Keller; A Distler
Journal:  Clin Nephrol       Date:  2000-09       Impact factor: 0.975

2.  Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis.

Authors:  Takako Saeki; Shinichi Nishi; Naofumi Imai; Tomoyuki Ito; Hajime Yamazaki; Mitsuhiro Kawano; Motohisa Yamamoto; Hiroki Takahashi; Shoko Matsui; Shinji Nakada; Tomoki Origuchi; Akira Hirabayashi; Noriyuki Homma; Yutaka Tsubata; Takuma Takata; Yoko Wada; Akihiko Saito; Sachiko Fukase; Kunihiro Ishioka; Kana Miyazaki; Yasufumi Masaki; Hisanori Umehara; Susumu Sugai; Ichiei Narita
Journal:  Kidney Int       Date:  2010-08-18       Impact factor: 10.612

3.  The Pathology of Sulfonamide Allergy in Man.

Authors:  R H More; G C McMillan; G L Duff
Journal:  Am J Pathol       Date:  1946-07       Impact factor: 4.307

4.  Nephropathy, an underestimated complication of methicillin therapy.

Authors:  S A Sanjad; G G Haddad; V H Nassar
Journal:  J Pediatr       Date:  1974-06       Impact factor: 4.406

5.  Reversible renal failure and nephrotic syndrome associated with nonsteroidal anti-inflammatory drugs.

Authors:  J H Brezin; S M Katz; A B Schwartz; J L Chinitz
Journal:  N Engl J Med       Date:  1979-12-06       Impact factor: 91.245

6.  Increased levels of urinary interleukin-6 in Kawasaki disease.

Authors:  K Ohta; A Seno; N Shintani; E Kato; A Yachie; H Seki; T Miyawaki; N Taniguchi
Journal:  Eur J Pediatr       Date:  1993-08       Impact factor: 3.183

7.  Acute interstitial nephritis associated with thiazide diuretics. Clinical and pathologic observations in three cases.

Authors:  A B Magil; H S Ballon; E C Cameron; A Rae
Journal:  Am J Med       Date:  1980-12       Impact factor: 4.965

Review 8.  Acute interstitial nephritis in children: a report of 13 cases and review of the literature.

Authors:  D Ellis; W A Fried; E J Yunis; E B Blau
Journal:  Pediatrics       Date:  1981-06       Impact factor: 7.124

9.  Analgesic and non-steroidal anti-inflammatory drug-associated acute renal failure: a prospective collaborative study.

Authors:  D Kleinknecht; P Landais; B Goldfarb
Journal:  Clin Nephrol       Date:  1986-06       Impact factor: 0.975

10.  ACUTE INTERSTITIAL NEPHRITIS.

Authors:  W T Councilman
Journal:  J Exp Med       Date:  1898-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.